Aeonian Biotech Ltd

South East, United Kingdom

Short Summary

A retail to supply the best research reagents to the IVD and CDx industries and to research facilities, based on disruptive proprietary. Orders have commenced and global recognition reached. Our aim is 1% of global market worth £7 billion.


Investment Raised
Previous Rounds N/A
Stage Achieving Sales
Investor Role Monthly Involvement


  • We have contracted a well-established distributor for better exposure.
  • The first sales went through that distributor, proving effectiveness.
  • Repeat order confirms a happy customer.
  • Second manufacturer contracted.
  • Third manufacturer in negotiation.
Please note: The content of this promotion has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000. Reliance on this promotion for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested. Investors should carry out their own due diligence and take professional advice where necessary.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

29% raised

Crystal Medical Group

location_on UAE

Growth stage opportunity to invest in an established healthcare brand operating within an emerging market (UAE) which will deliver a guaranteed exit within 3 years through a company listed company on AIM within the London Stock Exchange.

£ 600,000


£ 25,000

Min per Investor

Global Pro
0% raised

Prolgae Spirulina Protein

location_on India

Alternative plant-based protein is the future food for 10 Billion population in 2050. Plant-based Protein has a Billion dollar growing market for the next 10 Years. Spirulina has 65% protein which is even used in NASA for Astronauts.

£ 175,000


£ 50,000

Min per Investor

Global Pro
0% raised

Disease Diagnostics

location_on London, United Kingdom

The business consists of 3 main products: a diagnostic kit, image analysis software, and lab on tab hardware. In total, they combine to form a powerful all in one platform to diagnose any known disease via a novel technology developed by me earlier.

£ 500,000


£ 50,000

Min per Investor

load one similar proposal